Treatment of hepatitis C
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Sofosbuvir' scene='95/954110/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Sofosbuvir' scene='95/954110/Cv/1'> | ||
*[[Sofosbuvir]] | *[[Sofosbuvir]] | ||
| - | *[[Telaprevir]] | + | *[[Telaprevir]] inhibits the hepatitis C viral enzyme NS3/4A serine protease. |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 08:05, 28 February 2024
| |||||||||||
